amikacin has been researched along with Empyema in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A | 1 |
| Ito, T | 1 |
| Bergmann, P; Herchuelz, A; Thys, JP; Vanderhoeft, P; Yourassowsky, E | 1 |
3 other study(ies) available for amikacin and Empyema
| Article | Year |
|---|---|
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections | 1978 |
[Clinical experience with amikacin for respiratory infections due to gentamicin-resistant bacteria (author's transl)].
Topics: Aged; Amikacin; Drug Resistance, Microbial; Empyema; Female; Gentamicins; Humans; Kanamycin; Lung Abscess; Middle Aged; Respiratory Tract Infections | 1978 |
Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas.
Topics: Amikacin; Anti-Bacterial Agents; Biological Availability; Empyema; Gentamicins; Half-Life; Humans; Injections, Intravenous; Netilmicin; Pleural Effusion; Postoperative Complications; Time Factors | 1988 |